F Di Silverio
Overview
Explore the profile of F Di Silverio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
147
Citations
626
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boari A, Papa V, Di Silverio F, Aste G, Olivero D, Rocconi F
Vet Res Commun
. 2010 May;
34 Suppl 1:S107-10.
PMID: 20446034
Diabetes mellitus (DM) was diagnosed in a 6-year-old neutered male ferret with polyuria/polydipsia, symmetrical alopecia, and weight loss. Laboratory tests revealed severe hyperglycemia, glucosuria, and increased steroid hormone profile. Abdominal...
2.
Petrangeli E, Lenti L, Buchetti B, Chinzari P, Sale P, Salvatori L, et al.
J Cell Physiol
. 2008 Dec;
219(1):69-76.
PMID: 19067321
The molecular mechanism by which the lipido-sterolic extract of Serenoa repens (LSESr, Permixon) affects prostate cells remains to be fully elucidated. In androgen-independent PC3 prostate cancer cells, the LSESr-induced effects...
3.
Fioriti D, Mischitelli M, Di Monaco F, Di Silverio F, Petrangeli E, Russo G, et al.
J Cell Physiol
. 2008 May;
216(3):571-5.
PMID: 18481259
Prostate cancer (PC) is major common malignancy in males in most industrialized Western countries, where it is the most commonly diagnosed cancer affecting men after middle age (>50 years). Over...
4.
Fioriti D, Russo G, Mischitelli M, Anzivino E, Bellizzi A, Di Monaco F, et al.
Int J Immunopathol Pharmacol
. 2007 Jul;
20(2):405-11.
PMID: 17624255
The basic molecular mechanisms regulating prostate cancer (PCA) development and progression are very poorly understood. Different tumor suppressor genes are implicated in PCA. In particular, since the mutation rate of...
5.
Cardillo M, Di Silverio F
Int J Immunopathol Pharmacol
. 2006 Dec;
19(4):871-8.
PMID: 17166409
We investigated whether prostate - specific G protein couple receptor genes and STAG1/PMEPA1 gene expression in peripheral- blood could be useful as a diagnostic or prognostic marker of prostate cancer....
6.
Sciarra A, Cardi A, Dattilo C, Mariotti G, Di Monaco F, Di Silverio F
Int J Clin Pract
. 2006 Apr;
60(4):462-70.
PMID: 16620361
In this review, we will present some of the information that is known about neuroendocrine (NE) cells and differentiation in the prostate. We will then speculate on the potential role...
7.
Cardillo M, Gentile V, Di Silverio F
J Cell Biochem
. 2004 Sep;
93(4):641-3.
PMID: 15389976
No abstract available.
8.
Gentile V, Vicini P, Prigiotti G, Koverech A, Di Silverio F
Curr Med Res Opin
. 2004 Sep;
20(9):1377-84.
PMID: 15383186
Purpose: To investigate the efficacy and tolerability of oral propionyl-L-carnitine (PLC) plus sildenafil in men with erectile dysfunction (ED) and diabetes unresponsive to sildenafil monotherapy. Materials And Methods: Patients with...
9.
Di Silverio F, Gentile V, Pastore A, Voria G, Mariotti G, Sciarra A
Urol Int
. 2004 Apr;
72(3):179-88.
PMID: 15084759
Objectives: In an era when prevention is considered better than cure, is there a rationale for benign prostatic hyperplasia (BPH) prevention? Materials And Methods: Medline and Current Content databases were...
10.
De Berardinis E, Antonini G, Peters G, Loves W, van der Born K, Codacci-Pisanelli G, et al.
BJU Int
. 2004 Mar;
93(4):491-4.
PMID: 15008715
Objective: To determine, in a phase I trial, the local and systemic toxicity and pharmacodynamics of intravesical gemcitabine in patients with superficial bladder cancer. Patients And Methods: Twelve patients with...